Now available in the U.S., RED™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...
BOSTON--(BUSINESS WIRE)--Penumbra, Inc. (NYSE:PEN), a global interventional therapies company, today announced U.S. commercial availability of its most advanced thrombectomy device, the ACE™68 ...
Please provide your email address to receive an email when new articles are posted on . Penumbra announced it received FDA 510(k) clearance for its reperfusion catheter system designed to help ...
A Pivotal Step in Optimizing the ADAPT 2.0 Technique for Speed and Simplicity with a Single System Setup CAMPBELL, Calif.--(BUSINESS WIRE)--January 28, 2026-- Imperative Care, Inc. today announced the ...
The MarketWatch News Department was not involved in the creation of this content. Late-Breaking Data Presented at SNIS Suggest Lower Rates of Rescue Therapy Than Prior Thrombectomy Trials; Rapid ...
Physicians in Europe now have access to Penumbra’s latest stroke technology for mechanical thrombectomy RED® reperfusion catheters are designed with optimized trackability and aspiration efficiency to ...
Three highest enrolling sites reported 96% delivery of the super-bore HiPoint 88 Reperfusion System to MI occlusions and 84% first pass effect HiPoint 88 Reperfusion System secures 510(k) clearance ...
Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results